BOSTON (CBS) – Researchers at Mass General Hospital announced a breakthrough in treating Type 1 Diabetes. In a long-term study released Thursday, patients in a clinical trial had their blood sugar levels restored to near normal, with lasting results.

Patients in the trial received two doses of the bacillus Calmette-Guerin (BCG) vaccine, an inexpensive vaccine that is widely used to prevent tuberculosis. Results were not immediate, but after three years, every patient, “showed an improvement in HbA1c to near normal levels – improvement that persisted for the following five years,” MGH said in a news release.

“This is clinical validation of the potential to stably lower blood sugars to near normal levels with a safe vaccine, even in patients with longstanding disease,” said Dr. Denise Faustman, director of the MGH Immunobiology Laboratory, and the study’s senior author.

“It’s the first trial showing long-term reversal of diabetes,” Faustman told the Boston Business Journal.

A Phase 2 clinical trial is already underway. Researchers are hoping to mimic results from the first trial and zero in on the most effective dosing.

Comments (22)
  1. What a surprising discovery! As a father of a 18 year old son, living in Venezuela, you don´t imagine how anxious my wife and I are wating for something like. It is quite hard for us to get insulin, strips for measuring glucose, even needles! My email: espalla@gmail.com Eladio Bermudez

Leave a Reply

Please log in using one of these methods to post your comment:

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s